Department of Pediatric Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
Pediatr Obes. 2024 Nov;19(11):e13163. doi: 10.1111/ijpo.13163. Epub 2024 Sep 2.
Dietary interventions and increased physical activity are the cornerstones for management of the paediatric non-alcoholic fatty liver disease (NAFLD). Though, no specific diet has been proven superior, Indo-Mediterranean diet (IMD) has shown promise in adult literature. Thus, we aimed to compare the effect of IMD and a standard calorie-restricted diet (CRD) in Indian overweight children and adolescents with biopsy-proven NAFLD.
Thirty-nine consecutive biopsy-proven NAFLD children between the ages of 8 and 18 years were randomized into either IMD or CRD for 180 days, and various parameters were evaluated at baseline and then after 180 days (NCT05073588).
A total of 34 subjects (18 in IMD and 16 in CRD group) completed the study. There was a significantly higher decrease in controlled attenuation parameter (CAP) values (as a marker of hepatic steatosis; on transient elastography) (95% CI: 4.2-73.4, p = 0.042), weight (95% CI: 0.75-5.5, p = 0.046) and body mass index (BMI) (95% CI: 0.21-2.05, p = 0.014) (but not in Pediatric NAFLD Fibrosis Index or PNFI; as a marker of hepatic fibrosis) in IMD group compared to the CRD group. Liver stiffness measurement, serum cholesterol and low-density lipoprotein levels and HOMA-IR decreased only in the IMD group (p < 0.001). Our statistical model showed that delta-Weight was the only independent variable associated with delta-CAP.
Both IMD and CRD can improve the various anthropometric, clinical, imaging and biochemical parameters but IMD was superior to CRD in terms of reducing CAP values and weight/BMI over 180 days in overweight/obese NAFLD children.
饮食干预和增加身体活动是管理儿科非酒精性脂肪性肝病(NAFLD)的基石。虽然没有特定的饮食被证明是优越的,但印度地中海饮食(IMD)在成人文献中显示出了希望。因此,我们旨在比较 IMD 和标准热量限制饮食(CRD)在印度超重儿童和青少年中对经肝活检证实的 NAFLD 的影响。
39 名年龄在 8 至 18 岁之间的经肝活检证实的 NAFLD 儿童连续随机分为 IMD 或 CRD 组,进行 180 天的治疗,并在基线和 180 天后评估各种参数(NCT05073588)。
共有 34 名受试者(IMD 组 18 名,CRD 组 16 名)完成了研究。IMD 组受控衰减参数(CAP)值(作为肝脂肪变性的标志物;在瞬时弹性成像上)显著降低(95%CI:4.2-73.4,p=0.042),体重(95%CI:0.75-5.5,p=0.046)和体重指数(BMI)(95%CI:0.21-2.05,p=0.014)(但不是小儿非酒精性脂肪性肝病纤维化指数或 PNFI;作为肝纤维化的标志物)比 CRD 组高。IMD 组的肝硬度测量、血清胆固醇和低密度脂蛋白水平以及 HOMA-IR 降低(p<0.001)。我们的统计模型显示,Δ体重是唯一与Δ CAP 相关的独立变量。
IMD 和 CRD 均可改善各种人体测量、临床、影像学和生化参数,但 IMD 在超重/肥胖 NAFLD 儿童中,在 180 天内降低 CAP 值和体重/ BMI 方面优于 CRD。